Selected article for: "bacterial infection and early detection"
Author: Estella, Á.; Vidal-Cortés, P.; Rodríguez, A.; Andaluz Ojeda, D.; Martín-Loeches, I.; Díaz, E.; Suberviola, B.; Gracia Arnillas, M.P.; Catalán González, M.; Álvarez-Lerma, F.; Ramírez, P.; Nuvials, X.; Borges, M.; Zaragoza, R.
Title: Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU()
  • Cord-id: 6p2i3sqi
  • Document date: 2021_8_24
    • ID: 6p2i3sqi
    Snippet: Infections have become one of the main complications of patients with severe SARS-CoV-2 pneumonia admitted in ICU. Poor immune status, frequent development of organic failure requiring invasive supportive treatments, and prolonged ICU length of stay in saturated structural areas of patients are risk factors for infection development. The Working Group on Infectious Diseases and Sepsis GTEIS of the Spanish Society of Intensive Medicine and Coronary Units SEMICYUC emphasizes the importance of infe
    Document: Infections have become one of the main complications of patients with severe SARS-CoV-2 pneumonia admitted in ICU. Poor immune status, frequent development of organic failure requiring invasive supportive treatments, and prolonged ICU length of stay in saturated structural areas of patients are risk factors for infection development. The Working Group on Infectious Diseases and Sepsis GTEIS of the Spanish Society of Intensive Medicine and Coronary Units SEMICYUC emphasizes the importance of infection prevention measures related to health care, the detection and early treatment of major infections in the patient with SARS-CoV-2 infections. Bacterial co-infection, respiratory infections related to mechanical ventilation, catheter-related bacteremia, device-associated urinary tract infection and opportunistic infections are review in the document.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and liver renal: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver renal dysfunction: 1, 2, 3
    • acute ards respiratory distress syndrome and long duration: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and long therapy: 1
    • acute ards respiratory distress syndrome and low incidence: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and low sensitivity: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute ards respiratory distress syndrome and lymphocyte dysfunction: 1
    • acute phase and admission cephalosporin: 1
    • acute phase and liver renal: 1, 2, 3
    • acute phase and liver renal dysfunction: 1
    • acute phase and long duration: 1, 2, 3, 4, 5, 6
    • acute phase and long therapy: 1
    • acute phase and low incidence: 1, 2
    • acute phase and low sensitivity: 1, 2, 3, 4, 5, 6
    • acute phase and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory distress syndrome and acyclovir treatment: 1
    • acute respiratory distress syndrome and liver produce: 1
    • acute respiratory distress syndrome and liver renal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15